Company / Shares Outstanding
Ligand Pharmaceuticals, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
19.1M
FY2025
5-year range
16.1M / 19.1M
FY2021-FY2025
Trend
+8.8%
vs FY2024
Sector context
#201 of 212
Health Care
What the data says
Among 212 Health Care companies, Ligand Pharmaceuticals, Inc. is in the top 5% for shares outstanding. Shares Outstanding has increased for 4 consecutive years, from 16080000.00 in FY2021 to 19106000.00 in FY2025.
Based on SEC 10-K filings.
19106000.00 in FY2025 with a 5-year CAGR of +2.6%.
Increased from 16951000.00 to 19106000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +4.4%
- 5-Year CAGR
- +2.6%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 212This company 19.1M Sector average 306.7M
▼
-93.8% below sector average
Key checks
Key Insights
- Ligand Pharmaceuticals, Inc.'s shares outstanding has grown for 4 consecutive years.
- In FY2025, shares outstanding increased 8.8% year-over-year.
- Ranks #201 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2018.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 19.1M | +8.8% |
| FY2024 | 17.6M | +3.6% |
| FY2023 | 17.0M | +1.1% |
| FY2022 | 16.8M | +4.3% |
| FY2021 | 16.1M | -4.4% |
| FY2020 | 16.8M | -19.0% |
| FY2019 | 20.8M | -1.8% |
| FY2018 | 21.1M | +1.1% |
| FY2017 | 20.9M | +4.8% |
| FY2016 | 19.9M | +1.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026